(Q34235741)

English

KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Phlebotomus duboscqi

object named as

Phlebotomus duboscqi

1 reference

based on heuristic

inferred from title

object named as

Yasuyuki Goto

7

0 references

Fabiano Oliveira

object named as

Fabiano Oliveira

3

0 references

10

object named as

Steven G Reed

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jesus G Valenzuela

11

object named as

Jesus G Valenzuela

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Regis Gomes

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Clarissa Teixeira

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Phillip G Lawyer

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dia-Eldin Elnaiem

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Claudio Meneses

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ajay Bhatia

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Randall F Howard

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shaden Kamhawi

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

3 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PLoS Neglected Tropical Diseases

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

e1610

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

copyright license

Creative Commons CC0 License

3 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Vaccines for the leishmaniases: proposals for a research agenda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Leishmaniasis Vaccine: Where are We Today?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Optimized subunit vaccine protects against experimental leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Vector transmission of leishmania abrogates vaccine-induced protective immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Synthetic glycovaccine protects against the bite of leishmania-infected sand flies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Real-time PCR for detection and quantitation of leishmania in mouse tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Leishmaniasis: current status of vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The regulation of immunity to Leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

The present and future of vaccination for cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

T-cell responses and immunity to experimental infection with leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Functional heterogeneity of CD4+ T cells in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3317914

6 July 2018

Focus: Leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0001610

21 January 2018

Protection Against Cutaneous Leishmaniasis Resulting from Bites of Uninfected Sand Flies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22509423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of leishmanization in the control of cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22509423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22509423

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0001610

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34235741&oldid=2150157891"